FDA: Aseptic Meningitis Risk with Use of Seizure Drug Lamictal | Healthcare IT Blogs
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

FDA: Aseptic Meningitis Risk with Use of Seizure Drug Lamictal

Healthcare Blogs - Healthcare IT Blogs
Here's a recent warning from the FDA:

FDA: Aseptic Meningitis Risk with Use of Seizure Drug Lamictal

The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.

The agency is working with the drug’s manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.

Aseptic meningitis has a number of causes including, but not limited to, viruses, toxic agents, some vaccines, autoimmune diseases, and certain medications, including Lamictal. Symptoms can include headache, fever, chills, nausea, vomiting, stiff neck and sensitivity to light. Hospitalization may be required.

Read more here.

Trouble viewing the contents? Visit MedicineandTechnology.com

Become a fan of MedicineandTechnology on Facebook.


Read More: http://feedproxy.google.com/~r/mdjosephkim/~3/tO0piIhdmqw/fda-aseptic-meningitis-risk-with-use-of.html